Press release here. JUVE Patent and FOSS Patents both believe that this will terminate the referral to the CJEU on the issue of component-level licensing (see, e.g., here, here), though FOSS believes that another decision or decisions may lead to a referral down the road.
Update: Further discussion can be found on Bloomberg Law and Law360.
No comments:
Post a Comment